EKF DIAGNOST.HLDGS.LS-01
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that pr… Read more
EKF DIAGNOST.HLDGS.LS-01 (LYF) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, EKF DIAGNOST.HLDGS.LS-01 (LYF) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
EKF DIAGNOST.HLDGS.LS-01 - Net Assets Trend (None–None)
This chart illustrates how EKF DIAGNOST.HLDGS.LS-01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EKF DIAGNOST.HLDGS.LS-01 (None–None)
The table below shows the annual net assets of EKF DIAGNOST.HLDGS.LS-01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to EKF DIAGNOST.HLDGS.LS-01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
EKF DIAGNOST.HLDGS.LS-01 Competitors by Market Cap
The table below lists competitors of EKF DIAGNOST.HLDGS.LS-01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Major-Power Technology Co., Ltd.
TWO:6720
|
$102.44 Million |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
$102.46 Million |
|
BankFinancial Corporation
NASDAQ:BFIN
|
$102.49 Million |
|
Zhejiang Sunrise Garment Group Co Ltd
SHG:605138
|
$102.52 Million |
|
Kofola CeskoSlovensko as
PR:KOFOL
|
$102.40 Million |
|
GTC
F:G91
|
$102.39 Million |
|
25K0
F:25K0
|
$102.39 Million |
|
Goltas Goller Bolgesi Cimento Sanayi ve Ticaret AS
IS:GOLTS
|
$102.39 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EKF DIAGNOST.HLDGS.LS-01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares EKF DIAGNOST.HLDGS.LS-01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently EKF DIAGNOST.HLDGS.LS-01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares EKF DIAGNOST.HLDGS.LS-01's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EKF DIAGNOST.HLDGS.LS-01 (LYF) | €- | N/A | N/A | $102.41 Million |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |